Receptos Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 68

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $7.63B

Receptos General Information

Description

Operator of a biopharmaceutical company intended to discover, develop and commercialize innovative therapeutics for immune and autoimmune diseases. The company offers G protein-coupled receptor structure-based drug design technology and oral small-molecule therapeutic candidates, enabling healthcare providers and patients to access differentiated treatments for relapsing multiple sclerosis, inflammatory bowel disease and other immune-mediated conditions with improved safety and clinical efficacy.

Contact Information

Formerly Known As
Apoptos, Receptor Pharmaceuticals
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 3033 Science Park Road
  • Suite 300
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 3033 Science Park Road
  • Suite 300
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Receptos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 27-Aug-2015 $7.63B Completed Generating Revenue
6. Merger/Acquisition 11-Jun-2015 Cancelled Generating Revenue
5. Secondary Transaction - Open Market 02-Apr-2015 Completed Generating Revenue
4. Secondary Transaction - Open Market 07-Apr-2014 Completed Generating Revenue
3. IPO 09-May-2013 Completed Clinical Trials - Phase 2
2. Later Stage VC (Series B) 27-Mar-2013 $60M $87.6M Completed Generating Revenue
1. Early Stage VC (Series A) 23-Nov-2009 $27.6M $27.6M Completed Product Development
To view Receptos’s complete valuation and funding history, request access »

Receptos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Receptos’s complete cap table history, request access »

Receptos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to discover, develop and commercialize innovative therapeutics for immu
Drug Discovery
San Diego, CA
68 As of 2014

Evry Cedex, France
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Receptos Competitors (77)

One of Receptos’s 77 competitors is PEP-Therapy, a Venture Capital-Backed company based in Evry Cedex, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PEP-Therapy Venture Capital-Backed Evry Cedex, France
Enterome Venture Capital-Backed Paris, France
Centrexion Therapeutics Venture Capital-Backed Boston, MA
Adimab Venture Capital-Backed Lebanon, NH
Sorrento Therapeutics Formerly VC-backed San Diego, CA
You’re viewing 5 of 77 competitors. Get the full list »

Receptos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Receptos Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
ARCH Venture Partners Venture Capital Minority
Advanced Technology Ventures Venture Capital Minority
Altitude Life Science Ventures Venture Capital Minority
Flagship Pioneering Venture Capital Minority
Lilly Ventures Corporate Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Receptos FAQs

  • When was Receptos founded?

    Receptos was founded in 2007.

  • Where is Receptos headquartered?

    Receptos is headquartered in San Diego, CA.

  • What is the size of Receptos?

    Receptos has 68 total employees.

  • What industry is Receptos in?

    Receptos’s primary industry is Drug Discovery.

  • Is Receptos a private or public company?

    Receptos is a Private company.

  • What is the current valuation of Receptos?

    The current valuation of Receptos is .

  • What is Receptos’s current revenue?

    The current revenue for Receptos is .

  • How much funding has Receptos raised over time?

    Receptos has raised $156M.

  • Who are Receptos’s investors?

    ARCH Venture Partners, Advanced Technology Ventures, Altitude Life Science Ventures, Flagship Pioneering, and Lilly Ventures are 5 of 11 investors who have invested in Receptos.

  • Who are Receptos’s competitors?

    PEP-Therapy, Enterome, Centrexion Therapeutics, Adimab, and Sorrento Therapeutics are some of the 77 competitors of Receptos.

  • When was Receptos acquired?

    Receptos was acquired on 27-Aug-2015.

  • Who acquired Receptos?

    Receptos was acquired by Celgene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process